Segment And Enterprise-Wide Disclosures

3 Months Ended

Mar. 31, 2012

Segment And Enterprise-Wide Disclosures [Abstract]

Segment And Enterprise-Wide Disclosures

10. Segment and Enterprise-Wide Disclosures

The FASB establishes standards for reporting information regarding operating segments in annual financial statements. Operating segments are identified as components of an enterprise about which separate, discrete financial information is available for evaluation by the chief operating decision-maker in making decisions on how to allocate resources and assess performance. We view our operations and manage our business as one operating segment. No discrete operating information is prepared by us except for product sales by product line and by geographic location for local reporting purposes.

Most of our revenues were generated in the United States, Europe, and Japan, and substantially all of our assets are located in the United States. We analyze our sales using a number of approaches, including sales by legal entity. Our German subsidiary (LeMaitre Vascular GmbH) records all sales in Europe excluding direct sales in France (LeMaitre Vascular SAS); Italy (LeMaitre Vascular S.r.l.); and Spain (LeMaitre Vascular Spain SL) beginning July 1, 2011, and to distributors worldwide, excluding distributor sales in North, South and Central America (LeMaitre Vascular, Inc.), France (LeMaitre Vascular SAS), Portugal (LeMaitre Vascular Spain SL), and Korea and Taiwan (LeMaitre Vascular GK). Net sales to unaffiliated customers by legal entity were as follows:

	Three months ended March 31,
	2012		2011
	(in thousands)
LeMaitre Vascular, Inc.	$	9,474	$	9,002
LeMaitre Vascular GmbH		2,732		3,735
Other entities		1,722		1,861
Total	$	13,928	$	14,598

Upon our divestiture of the stent graft product lines, we reorganized our product categories from "Vascular", "Endovascular", and "General Surgery" to "Open Vascular" and "Endovascular and Other" as we re-focused our portfolio and sales channel on open vascular products. Net sales in these product categories were as follows:

	Three months ended March 31,
	2012		2011
	(in thousands)
Open Vascular	$	11,405	$	10,760
Endovascuar and Other		2,523		3,838
Total	$	13,928	$	14,598